Averna Therapeutics Inc. — Form D

Averna Therapeutics Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-17. The offering totals $85.0M, of which $38.8M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Alex HardingDirectorNew York, NY
Roy AmariglioExecutive OfficerWatertown, MA
Henry ChenDirectorBEDFORD, MA
Henry ChenRelated PersonBEDFORD, MA
Stephen SquintoDirectorStamford, CT
Stephen SquintoRelated PersonStamford, CT
Nick OlsenDirectorWatertown, MA
Nick OlsenRelated PersonWatertown, MA
DYLAN MORRISDirectorWatertown, MA
DYLAN MORRISRelated PersonWatertown, MA
Roy AmariglioDirectorWatertown, MA
Roy AmariglioRelated PersonWatertown, MA
Tal Zaks, M.D., Ph.D.DirectorWatertown, MA
Tal Zaks, M.D., Ph.D.Executive OfficerWatertown, MA
Raju Prasad, Ph.D.DirectorWatertown, MA
Thomas Barnes, Ph.D.DirectorWatertown, MA
Thomas Barnes, Ph.D.Executive OfficerWatertown, MA
Aaron NelsonDirectorNEW YORK, NY
Anat NursellaExecutive OfficerWatertown, MA
Tal ZaksDirectorWatertown, MA
Tal ZaksExecutive OfficerWatertown, MA
Tal ZaksRelated PersonWatertown, MA
Michal SilverbergDirectorWatertown, MA
Michal SilverbergRelated PersonWatertown, MA
Richard MorrisExecutive OfficerWatertown, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2026-03-20D/A$85.0M$85.0M
2025-04-21D/A$85.0M$43.8M

More